| Literature DB >> 33933842 |
Abstract
Dexmedetomidine has been increasingly introduced into the perioperative care of surgical patients. Because a subset of anesthetics/sedatives are immunomodulatory, it is critical to understand the role of dexmedetomidine in our host immune functions. Here we reviewed the role of dexmedetomidine in different immune cells. We also reviewed published clinical articles that described the role of dexmedetomidine in organ injury, cancer surgery, and infection. In animal studies, dexmedetomidine attenuated organ injury. In clinical studies, dexmedetomidine was associated with an improvement in outcomes in cardiac surgery and transplant surgery. However, there is a paucity in research examining how dexmedetomidine is associated with these outcomes. Further studies are needed to understand its clinical application from immunological standpoints.Entities:
Keywords: Dexmedetomidine; Leukocyte; Outcome
Mesh:
Substances:
Year: 2021 PMID: 33933842 PMCID: PMC8324520 DOI: 10.1016/j.intimp.2021.107709
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 5.714